Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome

Eleonora Candi, Manfredi Tesauro, Carmine Cardillo, Anna Maria Lena, Francesca Schinzari, Giuseppe Rodia, Giuseppe Sica, Paolo Gentileschi, Valentina Rovella, Margherita Annicchiarico-Petruzzelli, Nicola Di Daniele, Gerry Melino

Research output: Contribution to journalArticle

Abstract

Obesity represents one of the most complex public health challenges and has recently reached epidemic proportions. Obesity is also considered to be primarily responsible for the rising prevalence of metabolic syndrome, defined as the coexistence in the same individual of several risk factors for atherosclerosis, including dyslipidemia, hypertension and hyperglycemia, as well as for cancer. Additionally, the presence of three of the five risk factors (abdominal obesity, low high-density lipoprotein cholesterol, high triglycerides, high fasting glucose and high blood pressure) characterizes metabolic syndrome, which has serious clinical consequences. The current study was conducted in order to identify metabolic differences in visceral adipose tissue (VAT) collected from obese (body mass index 43–48) human subjects who were diagnosed with metabolic syndrome, obese individuals who were metabolically healthy and nonobese healthy controls. Extensive gas chromatography/mass spectrometry (GC/MS) and liquid chromatography/mass spectrometry (LC/MS/MS) analyses were used to obtain the untargeted VAT metabolomic profiles of 481 metabolites belonging to all biochemical pathways. Our results indicated consistent increases in oxidative stress markers from the pathologically obese samples in addition to subtle markers of elevated glucose levels that may be consistent with metabolic syndrome. In the tissue derived from the pathologically obese subjects, there were significantly elevated levels of plasmalogens, which may be increased in response to oxidative changes in addition to changes in glycerolphosphorylcholine, glycerolphosphorylethanolamine glycerolphosphorylserine, ceramides and sphingolipids. These data could be potentially helpful for recognizing new pathways that underlie the metabolic–vascular complications of obesity and may lead to the development of innovative targeted therapies.

Original languageEnglish
Pages (from-to)1019-1035
Number of pages17
JournalBiochemical Journal
Volume475
Issue number5
DOIs
Publication statusPublished - Mar 15 2018

Fingerprint

Intra-Abdominal Fat
Tissue
Mass spectrometry
Obesity
Plasmalogens
Glucose
Sphingolipids
Oxidative stress
Ceramides
Liquid chromatography
Blood pressure
Public health
Metabolites
Hypertension
Gas chromatography
HDL Cholesterol
Investigational Therapies
Metabolomics
Abdominal Obesity
Triglycerides

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Candi, E., Tesauro, M., Cardillo, C., Lena, A. M., Schinzari, F., Rodia, G., ... Melino, G. (2018). Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome. Biochemical Journal, 475(5), 1019-1035. https://doi.org/10.1042/BCJ20170604

Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome. / Candi, Eleonora; Tesauro, Manfredi; Cardillo, Carmine; Lena, Anna Maria; Schinzari, Francesca; Rodia, Giuseppe; Sica, Giuseppe; Gentileschi, Paolo; Rovella, Valentina; Annicchiarico-Petruzzelli, Margherita; Di Daniele, Nicola; Melino, Gerry.

In: Biochemical Journal, Vol. 475, No. 5, 15.03.2018, p. 1019-1035.

Research output: Contribution to journalArticle

Candi, E, Tesauro, M, Cardillo, C, Lena, AM, Schinzari, F, Rodia, G, Sica, G, Gentileschi, P, Rovella, V, Annicchiarico-Petruzzelli, M, Di Daniele, N & Melino, G 2018, 'Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome', Biochemical Journal, vol. 475, no. 5, pp. 1019-1035. https://doi.org/10.1042/BCJ20170604
Candi, Eleonora ; Tesauro, Manfredi ; Cardillo, Carmine ; Lena, Anna Maria ; Schinzari, Francesca ; Rodia, Giuseppe ; Sica, Giuseppe ; Gentileschi, Paolo ; Rovella, Valentina ; Annicchiarico-Petruzzelli, Margherita ; Di Daniele, Nicola ; Melino, Gerry. / Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome. In: Biochemical Journal. 2018 ; Vol. 475, No. 5. pp. 1019-1035.
@article{9882cfc27dfe487d9a5686aa8ab6d6ca,
title = "Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome",
abstract = "Obesity represents one of the most complex public health challenges and has recently reached epidemic proportions. Obesity is also considered to be primarily responsible for the rising prevalence of metabolic syndrome, defined as the coexistence in the same individual of several risk factors for atherosclerosis, including dyslipidemia, hypertension and hyperglycemia, as well as for cancer. Additionally, the presence of three of the five risk factors (abdominal obesity, low high-density lipoprotein cholesterol, high triglycerides, high fasting glucose and high blood pressure) characterizes metabolic syndrome, which has serious clinical consequences. The current study was conducted in order to identify metabolic differences in visceral adipose tissue (VAT) collected from obese (body mass index 43–48) human subjects who were diagnosed with metabolic syndrome, obese individuals who were metabolically healthy and nonobese healthy controls. Extensive gas chromatography/mass spectrometry (GC/MS) and liquid chromatography/mass spectrometry (LC/MS/MS) analyses were used to obtain the untargeted VAT metabolomic profiles of 481 metabolites belonging to all biochemical pathways. Our results indicated consistent increases in oxidative stress markers from the pathologically obese samples in addition to subtle markers of elevated glucose levels that may be consistent with metabolic syndrome. In the tissue derived from the pathologically obese subjects, there were significantly elevated levels of plasmalogens, which may be increased in response to oxidative changes in addition to changes in glycerolphosphorylcholine, glycerolphosphorylethanolamine glycerolphosphorylserine, ceramides and sphingolipids. These data could be potentially helpful for recognizing new pathways that underlie the metabolic–vascular complications of obesity and may lead to the development of innovative targeted therapies.",
author = "Eleonora Candi and Manfredi Tesauro and Carmine Cardillo and Lena, {Anna Maria} and Francesca Schinzari and Giuseppe Rodia and Giuseppe Sica and Paolo Gentileschi and Valentina Rovella and Margherita Annicchiarico-Petruzzelli and {Di Daniele}, Nicola and Gerry Melino",
year = "2018",
month = "3",
day = "15",
doi = "10.1042/BCJ20170604",
language = "English",
volume = "475",
pages = "1019--1035",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "5",

}

TY - JOUR

T1 - Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome

AU - Candi, Eleonora

AU - Tesauro, Manfredi

AU - Cardillo, Carmine

AU - Lena, Anna Maria

AU - Schinzari, Francesca

AU - Rodia, Giuseppe

AU - Sica, Giuseppe

AU - Gentileschi, Paolo

AU - Rovella, Valentina

AU - Annicchiarico-Petruzzelli, Margherita

AU - Di Daniele, Nicola

AU - Melino, Gerry

PY - 2018/3/15

Y1 - 2018/3/15

N2 - Obesity represents one of the most complex public health challenges and has recently reached epidemic proportions. Obesity is also considered to be primarily responsible for the rising prevalence of metabolic syndrome, defined as the coexistence in the same individual of several risk factors for atherosclerosis, including dyslipidemia, hypertension and hyperglycemia, as well as for cancer. Additionally, the presence of three of the five risk factors (abdominal obesity, low high-density lipoprotein cholesterol, high triglycerides, high fasting glucose and high blood pressure) characterizes metabolic syndrome, which has serious clinical consequences. The current study was conducted in order to identify metabolic differences in visceral adipose tissue (VAT) collected from obese (body mass index 43–48) human subjects who were diagnosed with metabolic syndrome, obese individuals who were metabolically healthy and nonobese healthy controls. Extensive gas chromatography/mass spectrometry (GC/MS) and liquid chromatography/mass spectrometry (LC/MS/MS) analyses were used to obtain the untargeted VAT metabolomic profiles of 481 metabolites belonging to all biochemical pathways. Our results indicated consistent increases in oxidative stress markers from the pathologically obese samples in addition to subtle markers of elevated glucose levels that may be consistent with metabolic syndrome. In the tissue derived from the pathologically obese subjects, there were significantly elevated levels of plasmalogens, which may be increased in response to oxidative changes in addition to changes in glycerolphosphorylcholine, glycerolphosphorylethanolamine glycerolphosphorylserine, ceramides and sphingolipids. These data could be potentially helpful for recognizing new pathways that underlie the metabolic–vascular complications of obesity and may lead to the development of innovative targeted therapies.

AB - Obesity represents one of the most complex public health challenges and has recently reached epidemic proportions. Obesity is also considered to be primarily responsible for the rising prevalence of metabolic syndrome, defined as the coexistence in the same individual of several risk factors for atherosclerosis, including dyslipidemia, hypertension and hyperglycemia, as well as for cancer. Additionally, the presence of three of the five risk factors (abdominal obesity, low high-density lipoprotein cholesterol, high triglycerides, high fasting glucose and high blood pressure) characterizes metabolic syndrome, which has serious clinical consequences. The current study was conducted in order to identify metabolic differences in visceral adipose tissue (VAT) collected from obese (body mass index 43–48) human subjects who were diagnosed with metabolic syndrome, obese individuals who were metabolically healthy and nonobese healthy controls. Extensive gas chromatography/mass spectrometry (GC/MS) and liquid chromatography/mass spectrometry (LC/MS/MS) analyses were used to obtain the untargeted VAT metabolomic profiles of 481 metabolites belonging to all biochemical pathways. Our results indicated consistent increases in oxidative stress markers from the pathologically obese samples in addition to subtle markers of elevated glucose levels that may be consistent with metabolic syndrome. In the tissue derived from the pathologically obese subjects, there were significantly elevated levels of plasmalogens, which may be increased in response to oxidative changes in addition to changes in glycerolphosphorylcholine, glycerolphosphorylethanolamine glycerolphosphorylserine, ceramides and sphingolipids. These data could be potentially helpful for recognizing new pathways that underlie the metabolic–vascular complications of obesity and may lead to the development of innovative targeted therapies.

UR - http://www.scopus.com/inward/record.url?scp=85046856074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046856074&partnerID=8YFLogxK

U2 - 10.1042/BCJ20170604

DO - 10.1042/BCJ20170604

M3 - Article

C2 - 29437994

AN - SCOPUS:85046856074

VL - 475

SP - 1019

EP - 1035

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 5

ER -